142 filings
Page 7 of 8
8-K
vce2ralk6
28 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
hdyj4i
21 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
c30gyqqmeuh yfp7d1q5
9 Mar 16
Akebia Prevails in European Patent Dispute and Preserves Access to Key Market for Vadadustat
12:00am
8-K
e6myooco yn8dorv6om
12 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
ihc4ec
5 Jan 16
Termination of a Material Definitive Agreement
12:00am
8-K
tit22c4
4 Jan 16
Other Events
12:00am
8-K
3zcth m3aai73j
14 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
mrm09c9ih40 lzicz81q
27 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
9ctpf t2y4
6 Oct 15
Akebia Reaches Agreement with FDA and EMA on Vadadustat Global Phase 3 Program
12:00am
8-K
ez5ad9
8 Sep 15
Akebia Announces Positive Top-Line Results from its Phase 2 Study of
12:00am
8-K
gijyd1e63k6pm6x5
11 Aug 15
Akebia Announces Second Quarter 2015 Financial Results
12:00am
8-K
mu0b2vr
15 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
tvp74 gfejh0h8
11 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
7bw5t9rh4i9ldc3
17 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
izx5gv6qp93br32n4dck
18 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
5twvxon7l3nu
27 Oct 14
Akebia Announces Positive Top-Line Results from its Phase 2b Study of
12:00am
8-K/A
9vz2evfqetj
22 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K/A
qz4poa js
22 Sep 14
Departure of Directors or Certain Officers
12:00am
8-K
udvsgd 5jz
15 Sep 14
Akebia Therapeutics Appoints Ronald C. Renaud Jr. to its Board of Directors
12:00am
8-K
2crs13hp61l
6 Aug 14
Akebia Therapeutics Announces Expansion of Management Team
12:00am